CytoGenix Announces Results of Influenza synDNA(TM) Vaccine Trial.

Extract


CytoGenix Announces Results of Influenza synDNA(TM) Vaccine Trial.

HOUSTON -- CytoGenix, Inc. (OTCBB:CYGX) announced today the successful completion of a genetic immunization animal trial using a synDNA(TM) va...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company